HealthCor Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

HealthCor Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-234,180	Closed	-$2.32M	–	92
2021 Q3	$2.32M	Hold	234,180	–	–	0.1%	57
2021 Q2	$2.39M	Sell	234,180 -100,000	-30%	-$1M	0.1%	59
2021 Q1	$3.36M	Buy	+334,180	New	+$3.56M	0.12%	69

Other funds holding EUCRU

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

HealthCor Management's EUCRU Position: Q4 2021 in Review

HealthCor Management sold out of Eucrates Biomedical Acquisition Corp. Unit (EUCRU) in Q4 2021, closing a stake of 234,180 shares — an estimated $2.32M sold.

HealthCor Management first reported a position in EUCRU in Q1 2021 and held it in 3 quarters. The position peaked at $3.36M in Q1 2021. 14 funds tracked by Wall St. Rank hold EUCRU as of Q4 2021.

HealthCor Management reported no remaining Eucrates Biomedical Acquisition Corp. Unit position as of Q4 2021 after selling out during the quarter.
HealthCor Management sold 234,180 Eucrates Biomedical Acquisition Corp. Unit shares in Q4 2021, an estimated $2.32M.
HealthCor Management first reported a position in Eucrates Biomedical Acquisition Corp. Unit in Q1 2021 and held it in 3 quarters.
HealthCor Management's Eucrates Biomedical Acquisition Corp. Unit position peaked at $3.36M in Q1 2021.
14 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Unit as of Q4 2021.

Based on HealthCor Management's 13F filing for Q4 2021, filed 14 Feb 2022.